{
  "crosswalk_id": "rx-ab0e4aebe25d",
  "dataset": {
    "version": "2026-11-15",
    "sha256": "966d20e4ebd28b02a5bf5709b5733de3f33bebb38b66ba9885ad48a836deddd2",
    "counts": {
      "acts": 47,
      "concepts": 25,
      "edges": 28,
      "obligations": 29,
      "measures": 43,
      "gaps": 32,
      "mitigations": 13,
      "equivalences": 27
    },
    "ledger_seq": 421
  },
  "concept": {
    "id": "oncology.dx.screening",
    "parent_id": "oncology.dx",
    "label_en": "Organised population screening",
    "definition": "Population-based, quality-assured early detection programmes in asymptomatic people (Council Recommendation 2022).",
    "domain": "pathway"
  },
  "from": "RO",
  "to": "NL",
  "summary": {
    "comparable_with_adjustment": 2,
    "not_comparable": 5
  },
  "steps": [
    {
      "step": {
        "id": "oncology.dx.screening",
        "label_en": "Organised population screening"
      },
      "eu_anchor": [
        {
          "id": "eu.bss.equipment",
          "article": "Art. 60–61",
          "strength": "binding",
          "act": {
            "act_id": "celex:32013L0059",
            "title": "Council Directive 2013/59/Euratom laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation (BSS)",
            "short_title": "Directive 2013/59/Euratom (BSS)",
            "url": "https://eur-lex.europa.eu/eli/dir/2013/59/oj",
            "binding": "binding_transposition"
          }
        },
        {
          "id": "eu.scr.quality",
          "article": "Points on organisation, quality assurance and monitoring",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": null,
        "measures": [
          {
            "id": "ro.plan.cancer",
            "type": "implementation",
            "article": "Legea 293/2022 (Planul național)",
            "summary": "Law establishing the National Cancer Prevention and Control Plan: screening, early diagnosis, registry and regional cancer centres; implementation by government decision.",
            "url": "https://www.anm.ro/_/LEGI%20ORDONANTE/Lege%20293-2022.pdf",
            "verification": "verified",
            "parameters": {}
          }
        ],
        "gaps": []
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": null,
        "measures": [
          {
            "id": "nl.scr.wbo",
            "type": "national_extension",
            "article": "WBO, permit requirement",
            "summary": "Population screening for cancer, or using ionising radiation, needs a ministerial permit after advice of the Health Council (Gezondheidsraad). This also covers commercial screening offers.",
            "url": "https://wetten.overheid.nl/BWBR0005699/",
            "verification": "secondary",
            "parameters": {
              "permit_required": true
            }
          }
        ],
        "gaps": [
          {
            "id": "gap.nl.wbo.permit",
            "direction": "national_to_eu",
            "gap_type": "exceeds",
            "severity": 2,
            "summary": "The WBO permit regime goes beyond the BSS justification rule: any cancer screening offer, including commercial or AI-supported screening, needs a permit. This is a market-access barrier specific to the Netherlands.",
            "verification": "secondary"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "comparable_with_adjustment",
      "reasons": [
        "gap.nl.wbo.permit: exceeds"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.breast",
        "label_en": "Breast cancer screening (mammography)"
      },
      "eu_anchor": [
        {
          "id": "eu.bss.justification",
          "article": "Art. 55",
          "strength": "binding",
          "act": {
            "act_id": "celex:32013L0059",
            "title": "Council Directive 2013/59/Euratom laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation (BSS)",
            "short_title": "Directive 2013/59/Euratom (BSS)",
            "url": "https://eur-lex.europa.eu/eli/dir/2013/59/oj",
            "binding": "binding_transposition"
          }
        },
        {
          "id": "eu.scr.breast",
          "article": "Point 1 and Annex (breast)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": {
          "concept_id": "oncology.dx.screening.breast",
          "jurisdiction_code": "RO",
          "term": "Screening pentru cancerul de sân (programe regionale)",
          "code_system": "Project-based, not in the CNAS package",
          "access": "Invitation where a regional project runs",
          "eligibility": "Per project (typically women 50–69)",
          "payer": "EU cohesion funds / Ministry of Health",
          "source_url": "https://www.adrcentru.ro/wp-content/uploads/2025/08/AP8.-Programul-Sanatate-Organizarea-unui-Program-national-de-prevenire-depistare-precoce-screening-si-diagnostic-al-cancerului-la-san.pdf",
          "verification": "secondary"
        },
        "measures": [
          {
            "id": "ro.scr.breast",
            "type": "programme",
            "article": "Programul Sănătate, Action 8 (regional breast screening and diagnosis)",
            "summary": "Breast cancer screening organised through EU-funded regional programmes rather than one permanent nationwide population programme.",
            "url": "https://www.adrcentru.ro/wp-content/uploads/2025/08/AP8.-Programul-Sanatate-Organizarea-unui-Program-national-de-prevenire-depistare-precoce-screening-si-diagnostic-al-cancerului-la-san.pdf",
            "verification": "secondary",
            "parameters": {}
          }
        ],
        "gaps": [
          {
            "id": "gap.ro.scr.breast",
            "direction": "eu_to_national",
            "gap_type": "partial",
            "severity": 3,
            "summary": "No permanent nationwide population-based breast screening programme; coverage depends on time-limited, region-based EU-funded projects.",
            "verification": "secondary"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": {
          "concept_id": "oncology.dx.screening.breast",
          "jurisdiction_code": "NL",
          "term": "Bevolkingsonderzoek borstkanker",
          "code_system": "RIVM programme (outside Zvw)",
          "access": "Invitation every 2 years",
          "eligibility": "Women 50–75",
          "payer": "State (programme budget)",
          "source_url": "https://www.rivm.nl/bevolkingsonderzoek-borstkanker",
          "verification": "cited_unverified"
        },
        "measures": [
          {
            "id": "nl.scr.breast",
            "type": "programme",
            "article": "National breast cancer screening programme (RIVM-CvB)",
            "summary": "Biennial mammography for women 50–75.",
            "url": "https://www.rivm.nl/bevolkingsonderzoek-borstkanker",
            "verification": "cited_unverified",
            "parameters": {
              "age_from": 50,
              "age_to": 75
            }
          }
        ],
        "gaps": [
          {
            "id": "gap.nl.breast.age",
            "direction": "national_to_eu",
            "gap_type": "exceeds",
            "severity": 0,
            "summary": "Upper age 75, as in Germany; age-band harmonisation needed when comparing interval cancers.",
            "verification": "cited_unverified"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "not_comparable",
      "reasons": [
        "gap.ro.scr.breast: partial",
        "gap.nl.breast.age: exceeds"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.cervical",
        "label_en": "Cervical cancer screening (HPV primary)"
      },
      "eu_anchor": [
        {
          "id": "eu.ivdr.devices",
          "article": "Art. 5, Art. 48, Annex VIII",
          "strength": "binding",
          "act": {
            "act_id": "celex:32017R0746",
            "title": "Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)",
            "short_title": "Reg. 2017/746 (IVDR)",
            "url": "https://eur-lex.europa.eu/eli/reg/2017/746/oj",
            "binding": "directly_applicable"
          }
        },
        {
          "id": "eu.scr.cervical",
          "article": "Point 1 and Annex (cervical)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": {
          "concept_id": "oncology.dx.screening.cervical",
          "jurisdiction_code": "RO",
          "term": "Screening pentru depistarea cancerului de col uterin",
          "code_system": "National health programme",
          "access": "Through family doctors and programme providers",
          "eligibility": "Per programme norms",
          "payer": "Ministry of Health programmes",
          "source_url": "https://ms.ro/media/documents/NF_HG_423_2022_PNS.pdf",
          "verification": "needs_research"
        },
        "measures": [
          {
            "id": "ro.scr.cervical",
            "type": "programme",
            "article": "National health programmes: cervical screening sub-programme",
            "summary": "Cervical cancer screening within the national health programmes, historically cytology (Babeș-Papanicolaou) based; HPV primary testing is being introduced through EU-funded projects.",
            "url": "https://ms.ro/media/documents/NF_HG_423_2022_PNS.pdf",
            "verification": "needs_research",
            "parameters": {
              "test": "cytology (HPV in projects)"
            }
          }
        ],
        "gaps": [
          {
            "id": "gap.ro.scr.cervical",
            "direction": "eu_to_national",
            "gap_type": "divergent",
            "severity": 2,
            "summary": "Cytology remains the primary test in the national programme, whereas the Recommendation prefers HPV primary testing; participation reported as low.",
            "verification": "needs_research"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": {
          "concept_id": "oncology.dx.screening.cervical",
          "jurisdiction_code": "NL",
          "term": "Bevolkingsonderzoek baarmoederhalskanker (hrHPV)",
          "code_system": "RIVM programme",
          "access": "Invitation; self-sampling kit available",
          "eligibility": "Women 30–60",
          "payer": "State (programme budget)",
          "source_url": "https://www.rivm.nl/bevolkingsonderzoek-baarmoederhalskanker",
          "verification": "cited_unverified"
        },
        "measures": [
          {
            "id": "nl.scr.cervical",
            "type": "programme",
            "article": "National cervical cancer screening programme (RIVM-CvB)",
            "summary": "Primary hrHPV testing for women 30–60 (self-sampling available), with cytology triage.",
            "url": "https://www.rivm.nl/bevolkingsonderzoek-baarmoederhalskanker",
            "verification": "cited_unverified",
            "parameters": {
              "age_from": 30,
              "age_to": 60,
              "test": "hrHPV"
            }
          }
        ],
        "gaps": [
          {
            "id": "gap.nl.scr.cervical",
            "direction": "eu_to_national",
            "gap_type": "divergent",
            "severity": 1,
            "summary": "Upper age 60 rather than 65; otherwise aligned (HPV primary).",
            "verification": "cited_unverified"
          }
        ]
      },
      "parameter_differences": [
        "test hrHPV (NL) vs cytology (HPV in projects) (RO)"
      ],
      "comparability": "comparable_with_adjustment",
      "reasons": [
        "gap.ro.scr.cervical: divergent",
        "gap.nl.scr.cervical: divergent"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.colorectal",
        "label_en": "Colorectal cancer screening (FIT)"
      },
      "eu_anchor": [
        {
          "id": "eu.ivdr.devices",
          "article": "Art. 5, Art. 48, Annex VIII",
          "strength": "binding",
          "act": {
            "act_id": "celex:32017R0746",
            "title": "Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)",
            "short_title": "Reg. 2017/746 (IVDR)",
            "url": "https://eur-lex.europa.eu/eli/reg/2017/746/oj",
            "binding": "directly_applicable"
          }
        },
        {
          "id": "eu.scr.colorectal",
          "article": "Point 1 and Annex (colorectal)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": {
          "concept_id": "oncology.dx.screening.colorectal",
          "jurisdiction_code": "RO",
          "term": "Screening cancer colorectal (proiecte pilot)",
          "code_system": "Project-based",
          "access": "Pilot regions only",
          "eligibility": "Per project",
          "payer": "EU funds",
          "source_url": null,
          "verification": "needs_research"
        },
        "measures": [
          {
            "id": "ro.scr.colorectal",
            "type": "programme",
            "article": "Regional colorectal screening projects",
            "summary": "Colorectal screening limited to regional, project-based pilots.",
            "url": null,
            "verification": "needs_research",
            "parameters": {}
          }
        ],
        "gaps": [
          {
            "id": "gap.ro.scr.colorectal",
            "direction": "eu_to_national",
            "gap_type": "partial",
            "severity": 3,
            "summary": "FIT-based organised screening for 50–74 is not available nationally; only pilots.",
            "verification": "needs_research"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": {
          "concept_id": "oncology.dx.screening.colorectal",
          "jurisdiction_code": "NL",
          "term": "Bevolkingsonderzoek darmkanker (FIT)",
          "code_system": "RIVM programme",
          "access": "Invitation every 2 years",
          "eligibility": "55–75",
          "payer": "State (programme budget)",
          "source_url": "https://www.rivm.nl/sites/default/files/2026-06/Uitvoeringskader-bvo-DK-versie-15.0.pdf",
          "verification": "verified"
        },
        "measures": [
          {
            "id": "nl.scr.colorectal",
            "type": "programme",
            "article": "WBO permit for the colorectal cancer screening programme",
            "summary": "Biennial FIT for people 55–75 with colonoscopy after a positive test.",
            "url": "https://www.rivm.nl/sites/default/files/2026-06/Uitvoeringskader-bvo-DK-versie-15.0.pdf",
            "verification": "verified",
            "parameters": {
              "age_from": 55,
              "age_to": 75,
              "test": "FIT"
            }
          }
        ],
        "gaps": [
          {
            "id": "gap.nl.scr.colorectal",
            "direction": "eu_to_national",
            "gap_type": "divergent",
            "severity": 1,
            "summary": "Programme starts at 55 instead of 50 (EU 50–74, NL 55–75). Results for people 50–54 are not comparable.",
            "verification": "verified"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "not_comparable",
      "reasons": [
        "gap.ro.scr.colorectal: partial",
        "gap.nl.scr.colorectal: divergent"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.gastric",
        "label_en": "Gastric cancer screening (H. pylori screen-and-treat)"
      },
      "eu_anchor": [
        {
          "id": "eu.scr.gastric",
          "article": "Point 2 (gastric)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": null,
        "measures": [],
        "gaps": [
          {
            "id": "gap.ro.scr.gastric",
            "direction": "eu_to_national",
            "gap_type": "not_implemented",
            "severity": 2,
            "summary": "Romania is among the EU countries with higher gastric cancer burden, so the screen-and-treat recommendation is relevant, but no programme or pilot was located.",
            "verification": "needs_research"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": null,
        "measures": [],
        "gaps": [
          {
            "id": "gap.nl.scr.gastric",
            "direction": "eu_to_national",
            "gap_type": "not_applicable",
            "severity": 0,
            "summary": "Recommendation targets high-incidence settings; the Netherlands is a low-incidence country.",
            "verification": "needs_research"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "not_comparable",
      "reasons": [
        "gap.ro.scr.gastric: not_implemented"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.lung",
        "label_en": "Lung cancer screening (low-dose CT)"
      },
      "eu_anchor": [
        {
          "id": "eu.bss.justification",
          "article": "Art. 55",
          "strength": "binding",
          "act": {
            "act_id": "celex:32013L0059",
            "title": "Council Directive 2013/59/Euratom laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation (BSS)",
            "short_title": "Directive 2013/59/Euratom (BSS)",
            "url": "https://eur-lex.europa.eu/eli/dir/2013/59/oj",
            "binding": "binding_transposition"
          }
        },
        {
          "id": "eu.scr.lung",
          "article": "Point 2 (lung)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": {
          "concept_id": "oncology.dx.screening.lung",
          "jurisdiction_code": "RO",
          "term": "Screening cancer pulmonar (inexistent)",
          "code_system": "None",
          "access": "Not available",
          "eligibility": "—",
          "payer": "—",
          "source_url": null,
          "verification": "needs_research"
        },
        "measures": [],
        "gaps": [
          {
            "id": "gap.ro.scr.lung",
            "direction": "eu_to_national",
            "gap_type": "not_implemented",
            "severity": 1,
            "summary": "No national evaluation or pilot of LDCT lung screening located.",
            "verification": "needs_research"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": {
          "concept_id": "oncology.dx.screening.lung",
          "jurisdiction_code": "NL",
          "term": "Longkankerscreening (alleen onderzoek)",
          "code_system": "None (research only)",
          "access": "Trials only",
          "eligibility": "Per study",
          "payer": "Research funding",
          "source_url": null,
          "verification": "needs_research"
        },
        "measures": [],
        "gaps": [
          {
            "id": "gap.nl.scr.lung",
            "direction": "eu_to_national",
            "gap_type": "partial",
            "severity": 1,
            "summary": "No national programme; evaluation happens in research settings (NL hosted the NELSON trial) and any programme would need a WBO permit.",
            "verification": "needs_research"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "not_comparable",
      "reasons": [
        "gap.ro.scr.lung: not_implemented",
        "gap.nl.scr.lung: partial"
      ]
    },
    {
      "step": {
        "id": "oncology.dx.screening.prostate",
        "label_en": "Prostate cancer screening (PSA with MRI)"
      },
      "eu_anchor": [
        {
          "id": "eu.ivdr.devices",
          "article": "Art. 5, Art. 48, Annex VIII",
          "strength": "binding",
          "act": {
            "act_id": "celex:32017R0746",
            "title": "Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)",
            "short_title": "Reg. 2017/746 (IVDR)",
            "url": "https://eur-lex.europa.eu/eli/reg/2017/746/oj",
            "binding": "directly_applicable"
          }
        },
        {
          "id": "eu.scr.prostate",
          "article": "Point 2 (prostate)",
          "strength": "recommendation",
          "act": {
            "act_id": "celex:32022H1214(01)",
            "title": "Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening (2022/C 473/01)",
            "short_title": "Council Rec. 2022 on cancer screening",
            "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022H1214(01)",
            "binding": "non_binding"
          }
        }
      ],
      "from": {
        "jurisdiction": "RO",
        "equivalent": null,
        "measures": [],
        "gaps": [
          {
            "id": "gap.ro.scr.prostate",
            "direction": "eu_to_national",
            "gap_type": "not_implemented",
            "severity": 1,
            "summary": "No organised PSA+MRI evaluation located.",
            "verification": "needs_research"
          }
        ]
      },
      "to": {
        "jurisdiction": "NL",
        "equivalent": null,
        "measures": [],
        "gaps": [
          {
            "id": "gap.nl.scr.prostate",
            "direction": "eu_to_national",
            "gap_type": "partial",
            "severity": 1,
            "summary": "No organised programme; research and pilot stage only.",
            "verification": "needs_research"
          }
        ]
      },
      "parameter_differences": [],
      "comparability": "not_comparable",
      "reasons": [
        "gap.ro.scr.prostate: not_implemented",
        "gap.nl.scr.prostate: partial"
      ]
    }
  ],
  "research_note": "Procedures for \"Organised population screening\" were translated from RO to NL using the EU legal anchor of each step as the common reference (Rosetta Stone crosswalk rx-ab0e4aebe25d, dataset 2026-11-15). Of 7 step(s), 0 are directly comparable, 2 comparable after adjustment for national parameters, 5 not comparable because one side lacks an implemented programme or route, and 0 unknown. Verification levels of each source are listed per step.",
  "citation": "Rosetta Stone (MVP). Cross-country procedure crosswalk rx-ab0e4aebe25d: Organised population screening, RO→NL. Dataset 2026-11-15. https://rosetta.covlescu.com/translate.html?concept=oncology.dx.screening&from=RO&to=NL",
  "url": "https://rosetta.covlescu.com/translate.html?concept=oncology.dx.screening&from=RO&to=NL",
  "disclaimer": "MVP research dataset compiled by hand from public legal sources; not legal or medical advice. Each row carries a verification level (verified, secondary, cited_unverified, needs_research); only \"verified\" rows were checked against the official text on the dataset date. Gap findings are \"proposed\" until reviewed."
}